2003

Jan 24, 2003
Guidant Commends New European Guideline for Defibrillator Implants

Enhanced Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Jan 22, 2003
Long-Term Follow-Up Clinical Data on Guidant's ANCURE Bifurcated System Demonstrates Continued Durability at Five Years

More Than 97 Percent of Patients Studied Experienced Stable or Shrinking Aneurysm Size Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jan 21, 2003
Guidant to Participate in U.S. Bancorp Piper Jaffray Health Care Conference

Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the treatment of cardiac and vascular disease, today announced that it...

Jan 17, 2003
Guidant Announces Live Webcast of its Fourth Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2002 earnings...

Jan 16, 2003
Guidant Announces European CE Mark and First Implant of Next-Generation Implantable Defibrillator

VITALITY AVT Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Show 5102550100 per page
Top